血小板激活抗血小板因子4疾病的分类
1Department of Pathology and Molecular Medicine, McMaster University, Ontario, Canada.
International journal of laboratory hematology
|May 13, 2025
概括
抗血小板因子4 (PF4) 疾病的范围正在扩大,包括肝素诱导的血小板缩和血栓形成 (HITT) 和疫苗诱导的免疫血小板缩和血栓形成 (VITT). 新的慢性形式和独立于肝素的变体需要更新的临床意识和管理策略,超越抗凝药.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 血栓形成的研究研究
背景情况:
- 氨酸诱导的血小板缺血和血栓形成 (HITT) 涉及针对血小板因子4 (PF4) 的IgG抗体,通常依赖于氨酸.
- 疫苗诱导的免疫性血栓缩和血栓形成 (VITT) 在2021年出现,由腺病毒载体疫苗引发,扩大了抗PF4疾病的范围.
- 这两种HITT和VITT抗体都通过Fcγ受体通路激活血小板.
研究的目的:
- 为了分类不断扩大的血小板激活抗PF4疾病的范围.
- 区分HITT类和VITT类疾病,包括急性和慢性表现.
主要方法:
- 从研究人员-临床医生的角度进行了一项文献综述,确定了新的抗PF4疾病.
- 分析重点关注各种抗PF4条件的临床表现,触发因素和免疫学特征.
主要成果:
- 鉴定了非典型的HITT变体,具有氨酸独立活性和自然腺病毒感染引起的VITT类疾病.
- 慢性抗PF4疾病,如具有血栓性意义的VITT类单克隆性甘马病 (VITT类MGTS),代表了一个新的,治疗不耐药的实体.
- 无论是HITT和VITT抗体都能识别出不同的PF4表位,并且管理可能需要除了抗凝血治疗之外的治疗,包括IVIG或IBRUTINIB用于VITT类MGTS.
结论:
- 临床医生和实验室人员必须意识到急性和慢性抗PF4疾病的不断变化的频谱.
- 了解这些区别对于准确的诊断和有效的患者管理至关重要.
- 识别新的抗PF4疾病需要更新的诊断和治疗方法.
关键词:
具有血栓性意义的VITT样单克隆性胃病变 (VITT样MGTS)这是一种自身免疫性疾病.肝素诱导的血小板缺血和血栓形成 (HITT)血小板因子4 (PF4) 是一个疫苗诱导的免疫性血小板缺血和血栓形成 (VITT)更多相关视频
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
548
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
548
01:18Structure and Function of Platelets
891
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
891
01:22Formation of the Platelet Plug
3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K
01:24Disorders of Hemostasis
651
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
651
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
396
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
396
01:16Clot Retraction and Fibrinolysis
2.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.9K